EGFR and cancer: Building on Stanley Cohen’s discoveries in the 1960s regarding the EGFR’s connection to malignancy, Dr. John Mendelsohn expanded this research in the 1980s and proposed that blocking EGFR signaling could serve as an effective anti-cancer treatment [44].